EAM
LXEO icon

Eventide Asset Management’s Lexeo Therapeutics LXEO Stock Holding History

Eventide Asset Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,234,834
Closed -$8.13M – 246
2024
Q4 		$8.13M Sell
1,234,834
-621,152
-33% -$4.89M 0.15% 138
2024
Q3 		$16.8M Sell
1,855,986
-1,513,161
-45% -$18M 0.29% 100
2024
Q2 		$54M Hold
3,369,147
– – 0.93% 35
2024
Q1 		$52.8M Buy
3,369,147
+366,316
+12% +$5.73M 0.83% 43
2023
Q4 		$40.3M Buy
+3,002,831
New +$37.3M 0.66% 53

Other funds holding LXEO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return